Noubar Afeyan @NoubarAfeyan · 26 Aug 2026
Pancreatic cancer was long considered one of medicine’s deadliest diagnoses. But today, the FDA approved @RevMedicines' Daraxonrasib - a new treatment that has in trials nearly doubled how long patients survive compared to standard chemotherapy. Daraxonrasib works by targeting a
12 960Views
89Likes
15Reposts
3Replies
2Quotes
19Bookmarks
Is that a lot?
4.60×vs this author's median2 816 views is typical
86Percentile for this authorof 7 recent posts
6.65×vs 10K–100K median1 948 views is typical
93.14%Reachviews ÷ followers
0.84%Engagement rateof viewers reacted